{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T05:52:35Z","timestamp":1767160355599,"version":"build-2238731810"},"reference-count":22,"publisher":"Informa UK Limited","issue":"6","funder":[{"name":"reported there is no funding associated"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biopharmaceutical Statistics"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1080\/10543406.2024.2330207","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T21:54:07Z","timestamp":1711144447000},"page":"1033-1044","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Assessing clinical response in early oncology development with a predictive biomarker"],"prefix":"10.1080","volume":"34","author":[{"given":"Shibing","family":"Deng","sequence":"first","affiliation":[{"name":"Translational Biomarker Statistics, Pfizer Research &amp; Development, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Oncology Research &amp; Development, Pfizer Inc, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadwiga","family":"Bienkowska","sequence":"additional","affiliation":[{"name":"ComputationalBiology, Oncology Research &amp; Development, Pfizer Inc, La Jolla, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,3,22]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.12.008"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.15.84"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S69718"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.3109\/07357907.2010.496759"},{"key":"e_1_3_3_6_1","unstructured":"EMEA (2005) Herceptin EPAR Scientific Discussion."},{"key":"e_1_3_3_7_1","unstructured":"FDA (2024) \u201cBiomarker guidances and reference materials\u201d https:\/\/www.fda.gov\/drugs\/biomarker-qualification-program\/biomarker-guidances-and-reference-materials#guidancer."},{"key":"e_1_3_3_8_1","unstructured":"Fornier M. Risio M. van Poznak C. and Seidman A. 2002. HER2 testing and correlation with efficacy of trastuzumab therapy. Oncol. 16 1340\u20131348. 1351\u20131352; discussion 1352 1355\u20131358."},{"key":"e_1_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2008.12.002"},{"key":"e_1_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/PO.19.00086"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1006448"},{"key":"e_1_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7064"},{"key":"e_1_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3984"},{"key":"e_1_3_3_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810699"},{"key":"e_1_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1080\/03610929808832194"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214886"},{"key":"e_1_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408440"},{"key":"e_1_3_3_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.010"},{"key":"e_1_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102019"},{"key":"e_1_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S156672"},{"key":"e_1_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1159\/000055400"},{"key":"e_1_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.683419"},{"key":"e_1_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2764"}],"updated-by":[{"DOI":"10.1080\/10543406.2024.2428565","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T00:00:00Z","timestamp":1732752000000}}],"container-title":["Journal of Biopharmaceutical Statistics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10543406.2024.2330207","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T08:58:49Z","timestamp":1732784329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10543406.2024.2330207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1080\/10543406.2024.2330207"],"URL":"https:\/\/doi.org\/10.1080\/10543406.2024.2330207","relation":{},"ISSN":["1054-3406","1520-5711"],"issn-type":[{"value":"1054-3406","type":"print"},{"value":"1520-5711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=lbps20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-09-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}